Correlation Between Ceragon Networks and Innovation Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ceragon Networks and Innovation Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ceragon Networks and Innovation Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ceragon Networks and Innovation Pharmaceuticals, you can compare the effects of market volatilities on Ceragon Networks and Innovation Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ceragon Networks with a short position of Innovation Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ceragon Networks and Innovation Pharmaceuticals.

Diversification Opportunities for Ceragon Networks and Innovation Pharmaceuticals

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Ceragon and Innovation is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Ceragon Networks and Innovation Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovation Pharmaceuticals and Ceragon Networks is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ceragon Networks are associated (or correlated) with Innovation Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovation Pharmaceuticals has no effect on the direction of Ceragon Networks i.e., Ceragon Networks and Innovation Pharmaceuticals go up and down completely randomly.

Pair Corralation between Ceragon Networks and Innovation Pharmaceuticals

Given the investment horizon of 90 days Ceragon Networks is expected to generate 23.96 times less return on investment than Innovation Pharmaceuticals. But when comparing it to its historical volatility, Ceragon Networks is 18.07 times less risky than Innovation Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Innovation Pharmaceuticals is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  2.00  in Innovation Pharmaceuticals on September 5, 2024 and sell it today you would lose (1.97) from holding Innovation Pharmaceuticals or give up 98.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ceragon Networks  vs.  Innovation Pharmaceuticals

 Performance 
       Timeline  
Ceragon Networks 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Ceragon Networks are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Ceragon Networks unveiled solid returns over the last few months and may actually be approaching a breakup point.
Innovation Pharmaceuticals 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Innovation Pharmaceuticals are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady forward indicators, Innovation Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Ceragon Networks and Innovation Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ceragon Networks and Innovation Pharmaceuticals

The main advantage of trading using opposite Ceragon Networks and Innovation Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ceragon Networks position performs unexpectedly, Innovation Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovation Pharmaceuticals will offset losses from the drop in Innovation Pharmaceuticals' long position.
The idea behind Ceragon Networks and Innovation Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Valuation
Check real value of public entities based on technical and fundamental data